乐博律师事务所的合伙人何伟康（Lewis Ho）律师在报道中谈道为何中国制药业的定价改革给生物科技公司在香港的上市过程带来拖延。
点击此链接在《南华早报》的网站阅读该份报道。该份报道也载于 The Street 和 Yahoo! News 的网站上。
-
合伙人
){kind=logo}
It looks like we may have content for your preferred language. Would you like to view this page in English?
Email has been submitted successfully. Thanks!
Error sending the email. Please try again later.
Error with download